tiprankstipranks
Nath Bio-Genes Submits Compliance Certificate for Q4 2024
Company Announcements

Nath Bio-Genes Submits Compliance Certificate for Q4 2024

Story Highlights

Stay Ahead of the Market:

An update from Nath Bio-Genes (India) Ltd. ( (IN:NATHBIOGEN) ) is now available.

Nath Bio-Genes (India) Limited has submitted a Compliance Certificate in accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending December 31, 2024. This submission confirms the dematerialization of securities, with the process involving verification and cancellation of security certificates, and updating the register of members with the depositories’ names as registered owners, ensuring compliance with listing requirements.

More about Nath Bio-Genes (India) Ltd.

YTD Price Performance: -9.84%

Average Trading Volume: 3,910

Current Market Cap: 3.29B INR

Learn more about NATHBIOGEN stock on TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App